- About ABC
- Contact Us
There are many coalitions consisting of other health advocacy or professional medical associations that circulate sign-on opportunities and ABC makes sure our voice joins these other groups in a more powerful alliance. Along with endorsing, we inform the membership about our decision and encourage them to sign-on and provide the contact information for the coalition coordinating the opportunity.
Below are the most recent letters the ABC has signed on to:
January 24, 2019 - Partnership for Part D 6 Protected Classes Letter
The American Brain Coalition signed on to a letter being circulated by the patient and provider community through the Partnership to Protect Part D Access regarding concerns on the Center for Medicare and Medicaid Services' proposed rule.
January 17, 2019 - Six Protected Classes Advertising Campaign
The American Brain Coalition joined American Cancer Society's Cancer Action Network as a partner in their advertising campaign regarding the 'Six Protected Classes'.
January 9, 2019 - NDD United's letter to Protect Domestic Programs
The American Brain Coalition signed on to NDD (nondefense discretionary) United’s letter urging Congress to protect NDD programs from further cuts and to end sequestration.
October 4, 2018 - Letter of Support for NABR DOT Complaint
The American Brain Coalition filed a letter of support for ABC member, National Association for Biomedical Research (NABR)’s official complaint with the US Department of Transportation regarding the refusal of major airlines to carry animals for the purpose of research.
September 25, 2018 - Neurological Conditions Surveillance System Thank You
A letter circulated by the The Michael J. Fox Foundation for Parkinson's Research and the National Multiple Sclerosis Society thanking members of Congress for the $5 million appropriation for the Neurological Conditions Surveillance System in the minibus appropriations bill.
September 10, 2018 - Multi-Society Letter in Support of OSTP Director to Senate Leadership
A letter circulated by the American Association for the Advancement of Sciences (AAAS) supporting the director of OSTP from scientific societies and organizations.
August 13, 2018 - Patient-Provider Letter to Centers for Medicare and Medicaid Services
A letter circulated by the American Academy of Neurology, urging the agency to reconsider a proposal in the 2019 Physician Fee Schedule to cut and consolidate Medicare evaluation and management (E/M) services.
A press release circulated by The Michael J Fox Foundation, American Lung Association, Endocrine Society, and AAAS for public health, scientific, and academic groups in response to EPA's proposed "Strengthening Transparency in Regulatory Science" Rule.
April 13th, 2018 - Friends of NIDA Letter - VA Medicinal Cannabis Research
A letter circulated by Friends of NIDA addressed to Chairman Roe and Ranking Member Walz of the House Committee on Veterans Affairs endorsing the, “VA Medicinal Cannabis Research Act of 2018.”
A letter circulated by Mental Health America commending FDA Commissioner Gottlieb on his consideration of a Center of Excellence for Neuroscience and encouraging him to consider psychiatry as part of that center.
December 20th, 2017 - Opposition of Actions which might Impede CDC Research
A letter circulated by The American Neurological Association opposing any action taken by the government to impede the life-saving research conducted by the CDC.
November 8th, 2017 - Appeal for the Orphan Drug Tax Credit
A letter circulated by The National Organization for Rare Disorders (NORD) opposing the proposal from the Senate Finance Committee to diminish the Orphan Drug Tax Credit.
September 5th, 2017 - Funding for National Neurological Diseases Surveillance System
A letter circulated by The National MS Society and the Michael J Fox Foundation urging Congress and the Administration to work together to raise the budget caps so that vital programs authorized under the 21st Century Cures Act can be funded appropriately through the appropriations process, including the National Neurological Diseases Surveillance System at the Centers for Disease Control and Prevention.